Abstract:Background Previous studies have suggested a strong association of liver fibrosis scores (LFSs) with cardiovascular outcomes in patients with different cardiovascular diseases. Nonetheless, it is basically blank regarding the prognostic significance of LFSs in patients following percutaneous coronary intervention (PCI). This study sought to examine the potential role of LFSs in predicting long‐term outcomes in a large cohort of patients with stable coronary artery disease after elective PCI. Methods and Results In this multicenter, prospective study, we consecutively enrolled 4003 patients with stable coronary artery disease undergoing PCI. Eight currently available noninvasive LFSs were assessed for each subject. All patients were followed up for the occurrence of cardiovascular events including cardiovascular death, nonfatal myocardial infarction, and stroke. During an average follow‐up of 5.0±1.6 years, 315 (7.87%) major cardiovascular events were recorded. Subjects who developed cardiovascular events were more likely to have intermediate or high LFSs, including nonalcoholic fatty liver disease fibrosis score; fibrosis‐4 score; body mass index, aspartate aminotransferase/alanine aminotransferase ratio, diabetes mellitus score (BARD); and aspartate aminotransferase/alanine aminotransferase ratio. Furthermore, compared with subjects with low scores, those with intermediate plus high score levels had significantly increased risk of cardiovascular events (adjusted hazard ratios ranging 1.57–1.92). Moreover, the addition of non‐alcoholic fatty liver disease fibrosis score; fibrosis‐4 score; or body mass index, aspartate aminotransferase/alanine aminotransferase ratio, diabetes mellitus score into a model with established cardiovascular risk factors significantly improved the prediction ability. Conclusions High LFSs levels might be useful for predicting adverse prognosis in patients with stable coronary artery disease following PCI, suggesting the possibility of the application of LFSs in the risk stratification before elective PCI. Nonstandard Abbreviations and Acronyms APRI aspartate aminotransferase to platelet ratio index BARD body mass index, aspartate aminotransferase/alanine aminotransferase ratio, diabetes mellitus score CVE cardiovascular event FIB‐4 fibrosis‐4 score LFS liver fibrosis score NAFLD nonalcoholic fatty liver disease NFS nonalcoholic fatty liver disease fibrosis score Clinical Perspective What Is New? Currently, no data are available regarding the prognostic significance of liver fibrosis scores in patients following percutaneous coronary intervention. The present study first indicated the clinical impact of liver fibrosis scores on long‐term outcomes in a large cohort of patients with stable coronary artery disease following percutaneous coronary intervention. What Are the Clinical Implications? In patients with coronary artery disease following elective percutaneous coronary intervention, liver fibrosis scores might be novel tools for risk stratification and clinical strategy‐making. Further studies regarding the role of liver fibrosis scores in diverse cardiovascular diseases may be of clinical interest. Although the management of coronary artery disease (CAD) has developed and improved dramatically over the past 2 decades, CAD remains a leading cause of morbidity and mortality worldwide. 1 Percutaneous coronary intervention (PCI) has significantly reduced the rate of major adverse cardiovascular events (CVEs) in patients with CAD. 2 , 3 , 4 , 5 However, patients who are post‐PCI still constitute a high‐risk group for recurrent events and cardiovascular m -Abstract Truncated-

Liver surgery-specific complications are an independent factor influencing long-term survival following major hepatectomy

Is It Feasible to Standardize a Composite Postoperative Complication Reporting System for Liver Resection?

ALBI and APRI score as prognostic factors for predicting the FABIB complications after liver resection in metastatic colorectal cancer.

The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection

Complications after liver surgery: a benchmark analysis

Investigating the influence of possible liver fibrosis on mortality in patients with coronary artery disease - a post-hoc ISCHEMIA trial analysis

An Integrated Liver Function, Systemic Inflammation, and Tumor Characteristic Score Predicts Prognosis in Hepatocellular Carcinoma After Curative Resection

Establishing the clinical relevance of grade A post‐hepatectomy liver failure

A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection

Colectomy in patients with liver disease: albumin-bilirubin score accurately predicts outcomes

Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD

Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC

Novel Composite Endpoint for Assessing Outcomes in Liver Transplantation: Arterial and Biliary Complication-Free Survival

Relationship between liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI

Preoperative leukocytosis and the resection severity index are independent risk factors for survival in patients with intrahepatic cholangiocarcinoma

Combination of advanced lung cancer inflammation index and nonalcoholic fatty liver disease fibrosis score as a promising marker for surgical procedure selection for hepatocellular carcinoma

Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications

Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis

Risk factors of hepatic failure after liver resection for perihilar cholangiocarcinoma: Importance of future liver remnant volume, body weight ratio, and impact on long-term survival.

FIB-4 and Severe Liver Disease Outcomes in Primary Care: A Stratified Cox Analysis